Trump’s Budget Slash Halts Groundbreaking HIV Research in Africa
South Africa’s BRILLIANT project — led by local scientists — was set to begin HIV vaccine trials using innovative mRNA technology, funded entirely by USAID
A week before trials were to begin, researchers received an email: “Stop all work.” US funding was immediately withdrawn
South African institutions are projected to lose ~$107 million in US research funding over the next five years, affecting HIV, TB, and other health studies
Following the aid cuts, viral load testing fell by up to 21% among pregnant women and infants. Clinics closed, and NGO‑run facilities were shuttered
UNAIDS warns that, unless funding is restored, millions more could die from AIDS by 2029. There are fears decades of progress could be reversed
South African trials were built around local genetic diversity and deep regional expertise. Now, this scientific momentum has been lost